Total Funding
84
64
Total FundingPost-IPO Equity raised
Growth Score
-3 pts
Heat Score
-6 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
14864
Capricor Therapeutics is a biotechnology company focusing on cell and exosome-based therapeutics.
Linda Marban: Co-Founder , President , CEO & Director- Michael Maurer: Chief Commercial OfficerPast Role: Amicus Therapeutics, Senior Vice President, Head of Global Marketing and New Product Strategy
About the Company
Capricor Therapeutics is a clinical-stage biotechnology company that focuses on the discovery, development, and commercialization of cell and exosome-based therapeutics for the treatment and prevention of diseases. Its CAP-1002 is an allogeneic cell therapy that is currently in clinical development for the treatment of Duchenne muscular dystrophy
and COVID-19.
The company was founded in 2005 and is headquartered in Los Angeles, California.
Women Founded
Women Led
